Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Enalare Therapeutics

Request full access

Developing novel therapies for patients suffering from acute respiratory conditions

Mantua Township, United StatesFounded 2019Biotech & Life Sciences

About Enalare Therapeutics

Enalare Therapeutics is a biopharmaceutical startup that focuses on developing novel compounds to address acute respiratory depression, a serious health issue that can lead to overdose deaths and complications in preterm infants and high-risk surgical patients. The company operates in the healthcare and pharmaceutical market, serving a broad range of clients including hospitals, healthcare providers, and potentially, patients directly.

The business model of Enalare Therapeutics is centered around the research, development, and commercialization of innovative pharmaceutical products. The company's revenue generation strategy is likely to involve the sale of these developed drugs to healthcare institutions or through prescription to patients.

The team at Enalare Therapeutics comprises experienced professionals from top-tier biopharma companies, scientific advisors of global repute, and a skilled workforce. They have a proven track record of developing and launching innovative products and creating significant shareholder value.

In summary, Enalare Therapeutics is a promising startup in the biopharmaceutical industry, with a focus on addressing acute respiratory depression through the development of novel compounds. Its experienced team and innovative approach position it well for future growth and success in the healthcare market.

Source: Dealroom company data

At a glance

Status
Operational
Employees
10
Open positions
None listed
Dealroom signal
68.7/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANT✓Other financing Sep 2024 $0 — US Department of Health and Human Services ↗
GRANT✓Other financing Feb 2023 $30K — New Jersey Economic Development Authority ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Enalare Therapeutics website traffic

Latest recorded traffic for Enalare Therapeutics is 3K monthly website visits, up 1900% over the last three months. Enalare Therapeutics's team declined 9.1% over the past year.

Latest monthly visits3K 3-month web change+1900% 1-year team growth-9.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Enalare Therapeutics in the Mantua Township ecosystem

Live from Dealroom

The Enalare Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • New Jersey Economic Development Authority
  • US Department of Health and Human Services

Series A1 investor entered at this stage

  • Eagle Pharmaceuticals

Other known investors2 additional known investors

  • DRIVe - Division of Research, Innovation, and Ventures
  • US Biomedical Advanced Research and Development Authority
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Enalare Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Enalare Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.